Legacy Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$250K Sell
2,587
-8
-0.3% -$705 0.04% 204
2026
Q2
$203K Sell
2,595
-636
-20% -$51.3K 0.04% 207
2026
Q1
$280K Sell
3,231
-10
-0.3% -$958 0.05% 179
2025
Q4
$311K Buy
3,241
+55
+2% +$5.34K 0.06% 164
2025
Q3
$303K Buy
+3,186
New +$293K 0.06% 159

Other funds holding MDT

Legacy Trust's MDT Position: Q3 2026 in Review

Legacy Trust reduced its Medtronic (MDT) stake by 0.31% in Q3 2026, selling an estimated $705 and leaving 2,587 shares worth $250K. The position accounts for 0.04% of the portfolio, ranked #204.

Legacy Trust first reported a position in MDT in Q3 2025 and has held it in 5 quarters since. The position peaked at $311K in Q4 2025. 1,360 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Legacy Trust held 2,587 shares of Medtronic worth $250K as of Q3 2026.
  • Legacy Trust sold 8 Medtronic shares in Q3 2026, an estimated $705.
  • Medtronic made up 0.04% of Legacy Trust's portfolio in Q3 2026, its #204 holding.
  • Legacy Trust first reported a position in Medtronic in Q3 2025 and has held it in 5 quarters since.
  • Legacy Trust's Medtronic position peaked at $311K in Q4 2025.
  • 1,360 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Legacy Trust's 13F filing for Q3 2026, filed 6 Nov 2026.